Background Metformin is a first-line drug in type 2 diabetes mellitus (T2DM) treatment, yet
whether metformin may increase all-cause or cardiovascular mortality of T2DM patients …

Type 2 diabetes mellitus (T2DM) remains substantial health problem and one of the most
prevalent metabolic diseases worldwide. The impact of T2DM on CV mortality and morbidity …

People with type 2 diabetes mellitus (T2DM) have two-to four-fold increased cardiovascular
mortality in comparison to the general population. With the identification of new therapeutic …

OBJECTIVE Patients with diabetes mellitus (DM) have elevated levels of high-sensitivity
cardiac troponin (hs-cTn). We investigated the diagnostic performance of the European …

Glycolipid metabolic disorders (GLMD) refer to a series of metabolic disorders caused by
abnormal processes of glucose and lipid synthesis, decomposition, and absorption in the …

CORTES, MARCIA et al. Performance of the European Society of Cardiology Algorithm for
the Assessment of Chest Pain in Patients with Diabetes Mellitus. Rev. argent …

Metformin is a drug that has been used for the treatment of diabetes for 65 years. Research
shows that metformin is a versatile drug that not only has beneficial effects on lowering …

Background Metformin has favorable effects on cardiovascular outcomes in both newly
onset and advanced type 2 diabetes, as previously reported findings from the UK …

Background: Patients with diabetes usually have higher troponin levels than the general
population. Objective: The aim of our study was to evaluate the performance of the …

Abstract The Side Effects of Drugs Annuals are yearly reviews of literature that has been
published on the adverse effects of drugs. The Side Effects of Drugs Annuals contributes to …